Portfolio (Quarterly)
Guide ↗
Lynx1 Capital Management LP
· CIK 0001910456| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | HOWL | WEREWOLF THERAPEUTICS INC | Healthcare | 657,786.0 | $237K | 0.03% | NEW | — | $0.36 | +157.9% |
| 22 | IMTX | IMMATICS N.V | Healthcare | 23,236.0 | $235K | 0.03% | NEW | — | $10.13 | -25.1% |
| 23 | — | AVALO THERAPEUTICS INC | — | 10,100.0 | $187K | 0.02% | NEW | — | $18.48 | — |
| 24 | BOLT | BOLT BIOTHERAPEUTICS INC | Healthcare | 30,800.0 | $119K | 0.01% | NEW | — | $3.85 | -10.4% |
| 25 | NUVB | NUVATION BIO INC | Healthcare | 16,029.0 | $91K | 0.01% | NEW | — | $5.68 | -9.5% |
| 26 | — | EUPRAXIA PHARMACEUTICALS INC | — | 10,000.0 | $66K | 0.01% | NEW | — | $6.61 | — |
| 27 | — | INHIBIKASE THERAPEUTICS INC | — | 20,000.0 | $41K | 0.01% | NEW | — | $2.03 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%